{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:32:36Z","timestamp":1778337156628,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s11060-017-2630-6","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T06:04:22Z","timestamp":1508911462000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Current and emerging treatment strategies for children with progressive chiasmatic-hypothalamic glioma diagnosed as infants: a web-based survey"],"prefix":"10.1007","volume":"136","author":[{"given":"Amedeo A.","family":"Azizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette Y. N.","family":"Schouten-van Meeteren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"2630_CR1","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1002\/cncr.24663","volume":"115","author":"I Qaddoumi","year":"2009","unstructured":"Qaddoumi I, Sultan I, Gajjar A (2009) Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the surveillance, epidemiology, and end results database. Cancer 115:5761\u20135770","journal-title":"Cancer"},{"key":"2630_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00250197","volume":"28","author":"M Garvey","year":"1996","unstructured":"Garvey M, Packer RJ (1996) An integrated approach to the treatment of chiasmatic-hypothalamic gliomas. J Neurooncol 28:167\u2013183","journal-title":"J Neurooncol"},{"key":"2630_CR3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/pbc.24729","volume":"61","author":"C Mirow","year":"2014","unstructured":"Mirow C, Pietsch T, Berkefeld S, Kwiecien R, Warmuth-Metz M, Falkenstein F, Diehl B, von Hornstein S, Gnekow AK (2014) Children <\u20091\u00a0year show an inferior outcome when treated according to the traditional LGG treatment strategy: a report from the German multicenter trial HIT-LGG 1996 for children with low grade glioma (LGG). Pediatr Blood Cancer 61:457\u2013463","journal-title":"Pediatr Blood Cancer"},{"key":"2630_CR4","first-page":"1257","volume":"12","author":"T Stokland","year":"2010","unstructured":"Stokland T, Liu JF, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker DA (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro Oncol 12:1257\u20131268","journal-title":"Neuro Oncol"},{"key":"2630_CR5","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/neuonc\/nos202","volume":"14","author":"AK Gnekow","year":"2012","unstructured":"Gnekow AK, Falkenstein F, von Hornstein S, Zwiener I, Berkefeld S, Bison B, Warmuth-Metz M, Driever PH, Soerensen N, Kortmann RD, Pietsch T, Faldum A (2012) Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro Oncol 14:1265\u20131284","journal-title":"Neuro Oncol"},{"key":"2630_CR6","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1200\/JCO.2003.03.043","volume":"21","author":"V Laithier","year":"2003","unstructured":"Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F, Pichon F, Rubie H, Frappaz D, Vannier JP, Babin-Boilletot A, Sariban E, Chastagner P, Zerah M, Raquin MA, Hartmann O, Kalifa C (2003) French Society of Pediatric O: progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy\u2014results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol 21:4572\u20134578","journal-title":"J Clin Oncol"},{"key":"2630_CR7","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00381-006-0086-7","volume":"22","author":"Y Ahn","year":"2006","unstructured":"Ahn Y, Cho BK, Kim SK, Chung YN, Lee CS, Kim IH, Yang SW, Kim HS, Kim HJ, Jung HW, Wang KC (2006) Optic pathway glioma: outcome and prognostic factors in a surgical series. Childs Nerv Syst 22:1136\u20131142","journal-title":"Childs Nerv Syst"},{"key":"2630_CR8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00381-011-1605-8","volume":"28","author":"M Hupp","year":"2012","unstructured":"Hupp M, Falkenstein F, Bison B, Mirow C, Krauss J, Gnekow A, Solymosi L, Warmuth-Metz M (2012) Infarction following chiasmatic low grade glioma resection. Childs Nerv Syst 28:391\u2013398","journal-title":"Childs Nerv Syst"},{"key":"2630_CR9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/cncr.29907","volume":"122","author":"R Krishnatry","year":"2016","unstructured":"Krishnatry R, Zhukova N, Guerreiro Stucklin AS, Pole JD, Mistry M, Fried I, Ramaswamy V, Bartels U, Huang A, Laperriere N, Dirks P, Nathan PC, Greenberg M, Malkin D, Hawkins C, Bandopadhayay P, Kieran MW, Manley PE, Bouffet E, Tabori U (2016) Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: a population-based study. Cancer 122:1261\u20131269","journal-title":"Cancer"},{"key":"2630_CR10","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1200\/JCO.2005.00.703","volume":"23","author":"RK Mulhern","year":"2005","unstructured":"Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A (2005) Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 23:5511\u20135519","journal-title":"J Clin Oncol"},{"key":"2630_CR11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11136-015-1091-7","volume":"25","author":"MA Ruiter de","year":"2016","unstructured":"de Ruiter MA, Schouten-van Meeteren AYN, van Vuurden DG, Maurice-Stam H, Gidding C, Beek LR, Granzen B, Oosterlaan J, Grootenhuis MA (2016) Psychosocial profile of pediatric brain tumor survivors with neurocognitive complaints. Qual Life Res 25:435\u2013446","journal-title":"Qual Life Res"},{"key":"2630_CR12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3171\/jns.1997.86.5.0747","volume":"86","author":"RJ Packer","year":"1997","unstructured":"Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747\u2013754","journal-title":"J Neurosurg"},{"key":"2630_CR13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejca.2017.04.019","volume":"81","author":"AK Gnekow","year":"2017","unstructured":"Gnekow AK, Walker DA, Kandels D, Picton S, Giorgio P, Grill J, Stokland T, Sandstrom PE, Warmuth-Metz M, Pietsch T, Giangaspero F, Schmidt R, Faldum A, Kilmartin D, De Paoli A, De Salvo GL, of the Low Grade Glioma C, the participating c (2017) A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (\u2264\u200916\u00a0years) low grade glioma: a final report. Eur J Cancer 81:206\u2013225","journal-title":"Eur J Cancer"},{"key":"2630_CR14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/pbc.21911","volume":"52","author":"V Haas de","year":"2009","unstructured":"de Haas V, Grill J, Raquin MA, Couanet D, Habrand JL, Sainte-Rose C, Laithier V, Kieffer V, Kalifa C (2009) Relapses of optic pathway tumors after first-line chemotherapy. Pediatr Blood Cancer 52:575\u2013580","journal-title":"Pediatr Blood Cancer"},{"key":"2630_CR15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/pbc.22917","volume":"57","author":"K Scheinemann","year":"2011","unstructured":"Scheinemann K, Bartels U, Tsangaris E, Hawkins C, Huang A, Dirks P, Fried I, Bouffet E, Tabori U (2011) Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas. Pediatr Blood Cancer 57:84\u201388","journal-title":"Pediatr Blood Cancer"},{"key":"2630_CR16","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.2011.34.5843","volume":"30","author":"E Bouffet","year":"2012","unstructured":"Bouffet E, Jakacki R, Goldman S, Hargrave D, Hawkins C, Shroff M, Hukin J, Bartels U, Foreman N, Kellie S, Hilden J, Etzl M, Wilson B, Stephens D, Tabori U, Baruchel S (2012) Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol 30:1358\u20131363","journal-title":"J Clin Oncol"},{"key":"2630_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1215\/15228517-2006-030","volume":"9","author":"S Gururangan","year":"2007","unstructured":"Gururangan S, Fisher MJ, Allen JC, Herndon JE, 2nd, Quinn JA, Reardon DA, Vredenburgh JJ, Desjardins A, Phillips PC, Watral MA, Krauser JM, Friedman AH, Friedman HS: Temozolomide in children with progressive low-grade glioma. Neuro Oncol 9: 161\u2013168, 2007","journal-title":"Neuro Oncol"},{"key":"2630_CR18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/cncr.20042","volume":"100","author":"R Soffietti","year":"2004","unstructured":"Soffietti R, Nobile M, Ruda R, Borgognone M, Costanza A, Laguzzi E, Mutani R (2004) Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study. Cancer 100:807\u2013813","journal-title":"Cancer"},{"key":"2630_CR19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ijc.29711","volume":"138","author":"AJ Dodgshun","year":"2016","unstructured":"Dodgshun AJ, Maixner WJ, Heath JA, Sullivan MJ, Hansford JR (2016) Single agent carboplatin for pediatric low-grade glioma: a retrospective analysis shows equivalent efficacy to multiagent chemotherapy. Int J Cancer 138:481\u2013488","journal-title":"Int J Cancer"},{"key":"2630_CR20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/pbc.21935","volume":"52","author":"RJ Packer","year":"2009","unstructured":"Packer RJ, Jakacki R, Horn M, Rood B, Vezina G, MacDonald T, Fisher MJ, Cohen B (2009) Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan. Pediatr Blood Cancer 52:791\u2013795","journal-title":"Pediatr Blood Cancer"},{"key":"2630_CR21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/neuonc\/not154","volume":"16","author":"S Gururangan","year":"2014","unstructured":"Gururangan S, Fangusaro J, Poussaint TY, McLendon RE, Onar-Thomas A, Wu S, Packer RJ, Banerjee A, Gilbertson RJ, Fahey F, Vajapeyam S, Jakacki R, Gajjar A, Goldman S, Pollack IF, Friedman HS, Boyett JM, Fouladi M, Kun LE (2014) Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas: a Pediatric Brain Tumor Consortium study. Neuro Oncol 16:310\u2013317","journal-title":"Neuro Oncol"},{"key":"2630_CR22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jamaophthalmol.2013.5819","volume":"132","author":"RA Avery","year":"2014","unstructured":"Avery RA, Hwang EI, Jakacki RI, Packer RJ (2014) Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab. JAMA Ophthalmol 132:111\u2013114","journal-title":"JAMA Ophthalmol"},{"key":"2630_CR23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/pbc.24297","volume":"60","author":"EI Hwang","year":"2013","unstructured":"Hwang EI, Jakacki RI, Fisher MJ, Kilburn LB, Horn M, Vezina G, Rood BR, Packer RJ (2013) Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas. Pediatr Blood Cancer 60:776\u2013782","journal-title":"Pediatr Blood Cancer"},{"key":"2630_CR24","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/neuonc\/nor090","volume":"13","author":"RI Jakacki","year":"2011","unstructured":"Jakacki RI, Bouffet E, Adamson PC, Pollack IF, Ingle AM, Voss SD, Blaney SM (2011) A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children\u2019s Oncology Group phase 1 consortium study. Neuro Oncol 13:910\u2013915","journal-title":"Neuro Oncol"},{"key":"2630_CR25","doi-asserted-by":"crossref","first-page":"e53-56","DOI":"10.1097\/MPH.0b013e318257a6ca","volume":"35","author":"G Singh","year":"2013","unstructured":"Singh G, Wei XC, Hader W, Chan JA, Bouffet E, Lafay-Cousin L (2013) Sustained response to weekly vinblastine in 2 children with pilomyxoid astrocytoma associated with diencephalic syndrome. J Pediatr Hematol Oncol 35:e53-56","journal-title":"J Pediatr Hematol Oncol"},{"key":"2630_CR26","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/cam4.699","volume":"5","author":"MA Heng","year":"2016","unstructured":"Heng MA, Padovani L, Dory-Lautrec P, Gentet JC, Verschuur A, Pasquier E, Figarella-Branger D, Scavarda D, Andre N (2016) Can metronomic maintenance with weekly vinblastine prevent early relapse\/progression after bevacizumab-irinotecan in children with low-grade glioma? Cancer Med 5:1542\u20131545","journal-title":"Cancer Med"},{"key":"2630_CR27","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1200\/JCO.2002.08.087","volume":"20","author":"M Massimino","year":"2002","unstructured":"Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, Riva D, Ruggiero A, Valentini L, Mazza E, Genitori L, Di Rocco C, Navarria P, Casanova M, Ferrari A, Luksch R, Terenziani M, Balestrini MR, Colosimo C, Fossati-Bellani F (2002) High response rate to cisplatin\/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20:4209\u20134216","journal-title":"J Clin Oncol"},{"key":"2630_CR28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11060-010-0136-6","volume":"100","author":"M Massimino","year":"2010","unstructured":"Massimino M, Spreafico F, Riva D, Biassoni V, Poggi G, Solero C, Gandola L, Genitori L, Modena P, Simonetti F, Potepan P, Casanova M, Meazza C, Clerici CA, Catania S, Sardi I, Giangaspero F (2010) A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma. J Neurooncol 100:65\u201371","journal-title":"J Neurooncol"},{"key":"2630_CR29","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/1097-0142(19850615)55:12<2741::AID-CNCR2820551202>3.0.CO;2-2","volume":"55","author":"I Djerassi","year":"1985","unstructured":"Djerassi I, Kim JS, Reggev A (1985) Response of astrocytoma to high-dose methotrexate with citrovorum factor rescue. Cancer 55:2741\u20132747","journal-title":"Cancer"},{"key":"2630_CR30","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3171\/jns.1985.63.6.0862","volume":"63","author":"JG Rosenstock","year":"1985","unstructured":"Rosenstock JG, Packer RJ, Bilaniuk L, Bruce DA, Radcliffe JL, Savino P (1985) Chiasmatic optic glioma treated with chemotherapy: a preliminary report. J Neurosurg 63:862\u2013866","journal-title":"J Neurosurg"},{"key":"2630_CR31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/1097-0142(19950215)75:4<1051::AID-CNCR2820750423>3.0.CO;2-S","volume":"75","author":"AJ Janss","year":"1995","unstructured":"Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, Goldwein JW, Sutton LN, Radcliffe J, Molloy PT et al (1995) Optic pathway and hypothalamic\/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 75:1051\u20131059","journal-title":"Cancer"},{"key":"2630_CR32","doi-asserted-by":"crossref","first-page":"e341-346","DOI":"10.1097\/MPH.0000000000000371","volume":"37","author":"M Kalra","year":"2015","unstructured":"Kalra M, Heath JA, Kellie SJ, Dalla Pozza L, Stevens MM, Swamy S, McCowage GB (2015) Confirmation of bevacizumab activity, and maintenance of efficacy in retreatment after subsequent relapse, in pediatric low-grade glioma. J Pediatr Hematol Oncol 37:e341-346","journal-title":"J Pediatr Hematol Oncol"},{"key":"2630_CR33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/pbc.22409","volume":"54","author":"B Reismuller","year":"2010","unstructured":"Reismuller B, Azizi AA, Peyrl A, Heinrich M, Gruber-Olipitz M, Luckner D, Rothschild KV, Slavc I (2010) Feasibility and tolerability of bevacizumab in children with primary CNS tumors. Pediatr Blood Cancer 54:681\u2013686","journal-title":"Pediatr Blood Cancer"},{"key":"2630_CR34","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1002\/cncr.28343","volume":"119","author":"J Fangusaro","year":"2013","unstructured":"Fangusaro J, Gururangan S, Poussaint TY, McLendon RE, Onar-Thomas A, Warren KE, Wu S, Packer RJ, Banerjee A, Gilbertson RJ, Jakacki R, Gajjar A, Goldman S, Pollack IF, Friedman HS, Boyett JM, Kun LE, Fouladi M (2013) Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022). Cancer 119:4180\u20134187","journal-title":"Cancer"},{"key":"2630_CR35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/annonc\/mdm510","volume":"19","author":"M Benesch","year":"2008","unstructured":"Benesch M, Windelberg M, Sauseng W, Witt V, Fleischhack G, Lackner H, Gadner H, Bode U, Urban C (2008) Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors. Ann Oncol 19:807\u2013813","journal-title":"Ann Oncol"},{"key":"2630_CR36","doi-asserted-by":"crossref","first-page":"e24-27","DOI":"10.1200\/JCO.2012.43.6733","volume":"31","author":"J Fangusaro","year":"2013","unstructured":"Fangusaro J, Gururangan S, Jakacki RI, Kaste SC, Goldman S, Pollack IF, Boyett JM, Kun LE (2013) Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors. J Clin Oncol 31:e24-27","journal-title":"J Clin Oncol"},{"key":"2630_CR37","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00018-011-0898-9","volume":"69","author":"DT Jones","year":"2012","unstructured":"Jones DT, Gronych J, Lichter P, Witt O, Pfister SM (2012) MAPK pathway activation in pilocytic astrocytoma. Cell Mol Life Sci 69:1799\u20131811","journal-title":"Cell Mol Life Sci"},{"key":"2630_CR38","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/neuonc\/nou059","volume":"16","author":"MA Karajannis","year":"2014","unstructured":"Karajannis MA, Legault G, Fisher MJ, Milla SS, Cohen KJ, Wisoff JH, Harter DH, Goldberg JD, Hochman T, Merkelson A, Bloom MC, Sievert AJ, Resnick AC, Dhall G, Jones DT, Korshunov A, Pfister SM, Eberhart CG, Zagzag D, Allen JC (2014) Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro Oncol 16:1408\u20131416","journal-title":"Neuro Oncol"},{"key":"2630_CR39","doi-asserted-by":"crossref","unstructured":"Banerjee A, Jakacki R, Onar-Thomas A, Wu SJ, Nicolaides T, Turner D, Richardson S, Young-Poussaint T, Phillips JJ, Prados M, Packer R, Qaddoumi IA, Gururangan S, Goldman S, Pollack I, Doyle LA, Stewart CF, Boyett JM, Fouladi M: A phase I study of AZD6244 in children with recurrent or refractory low-grade gliomas: a Pediatric Brain Tumor Consortium report. J Clin Oncol 32, 2014","DOI":"10.1200\/jco.2014.32.15_suppl.10065"},{"key":"2630_CR40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/neuonc\/nox083.141","volume":"19","author":"J Fangusaro","year":"2017","unstructured":"Fangusaro J, Onar-Thomas A, Poussaint TY, Wu SJ, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Pollack IF, Jakacki RI, Qaddoumi I, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Pfister SM, Jones DTW, Vezina G, Stern J, Panigrahy A, Jones BV, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Doyle LA, Smith M, Boyett JM, Dunkel IJ, Fouladi M (2017) A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study. Neuro Oncol 19:34\u201335","journal-title":"Neuro Oncol"},{"key":"2630_CR41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11060-005-9091-z","volume":"78","author":"M Benesch","year":"2006","unstructured":"Benesch M, Lackner H, Sovinz P, Suppan E, Schwinger W, Eder HG, Dornbusch HJ, Moser A, Triebl-Roth K, Urban C (2006) Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long-term survivors treated between 1983 and 2003. J Neurooncol 78:199\u2013205","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2630-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2630-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2630-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T12:12:44Z","timestamp":1603195964000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2630-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["2630"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2630-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]}}}